Skip to main content
SEOUL PHARMA CO.,LTD logo

SEOUL PHARMA CO.,LTD — Investor Relations & Filings

Ticker · 018680 ISIN · KR7018680009 KO Manufacturing
Open in API
Filings indexed 151 across all filing types
Latest filing 2020-12-15 Regulatory Filings
Country KR South Korea
Listing KO 018680

About SEOUL PHARMA CO.,LTD

http://www.seoulpharmaceuticals.com/

Seoul Pharma Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and sale of pharmaceutical products. The company specializes in innovative drug delivery systems, with a core competency in Orally Disintegrating Film (ODF) technology. Its product portfolio includes a wide range of prescription and over-the-counter medications. Key therapeutic areas cover cardiovascular and respiratory systems, as well as anti-infective agents such as antibacterials, antifungals, and antivirals. The company also produces vitamins and antibiotics, aiming to improve health outcomes through its cutting-edge technological capabilities.

Recent filings

Filing Released Lang Actions
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a formal notice regarding the suspension of share registration (stock transfer) and the closing of the shareholder register for Seoul Pharma. This is a standard regulatory announcement related to corporate actions and shareholder rights, specifically to determine the list of shareholders eligible to vote at the upcoming Annual General Meeting. Since it is a regulatory announcement regarding corporate administrative procedures and does not fit into specific categories like dividend announcements or financial reports, it is classified as a general regulatory filing.
2020-12-15 Korean
분기보고서 (2020.09)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Seoul Pharma, covering the period from 2020-01-01 to 2020-09-30. It contains detailed financial information, management discussion, and corporate data, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2020
2020-11-16 Korean
[기재정정]사업보고서 (2019.12)
Audit Report / Information Classification · 100% confidence The document is a 'Correction Report' (정정신고) for an Audit Report (감사보고서) of Seoul Pharma (주식회사 서울제약). It explicitly states it is a correction of a previously submitted audit report due to financial statement restatements (revenue, accounts receivable, cost of goods sold, etc.). It includes the independent auditor's report, balance sheets, income statements, and notes to the financial statements. Since it is a formal audit report document (even if it is a correction/restatement), it falls under the Audit Report category. FY 2019
2020-08-14 Korean
[첨부정정]사업보고서 (2016.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for Seoul Pharma, specifically detailing a restatement of financial statements due to errors. It includes the independent auditor's report, corrected financial statements (balance sheet, income statement, etc.), and notes on the restatement. While it is a correction filing, it contains the full audit report content rather than just an announcement, fitting the 'Audit Report / Information' category. FY 2016
2020-08-14 Korean
반기보고서 (2020.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for Seoul Pharma, covering the period from January 1, 2020, to June 30, 2020. It contains detailed financial information, management discussion, and corporate governance data, which fits the definition of an Interim/Quarterly Report (IR). H1 2020
2020-08-14 Korean
[기재정정]감사보고서제출(2016년 감사보고서 재발행)
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from Seoul Pharma (서울제약) titled 'Correction Report' (정정신고) regarding a previously submitted Audit Report (감사보고서). It details specific financial corrections for the 2016 fiscal year, including adjustments to assets, liabilities, and net income. Since this is a formal regulatory correction of financial data rather than the primary annual report itself, and it does not fit into the other specific categories like 10-K or IR, it is classified as a Regulatory Filing (RNS). FY 2016
2020-08-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.